Gene · 25913
Papers2,597
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 2,597
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Increased post-mitotic senescence in aged human neurons is a pathological feature of Alzheimer's disease. | Cell Stem Cell | 2022 | 36459967 | PubTator, text mining | PubMed |
| Deciphering RNA G-quadruplex function during the early steps of HIV-1 infection. | Nucleic Acids Res | 2022 | 36453997 | PubTator, text mining | PubMed |
| The germline mutational landscape of genitourinary cancers and its indication for prognosis and risk. | BMC Urol | 2022 | 36451132 | PubTator, text mining | PubMed |
| High-Throughput Analysis Reveals miRNA Upregulating α-2,6-Sialic Acid through Direct miRNA-mRNA Interactions. | ACS Cent Sci | 2022 | 36439307 | PubTator, text mining | PubMed |
| Mitochondrial topoisomerase 1 inhibition induces topological DNA damage and T cell dysfunction in patients with chronic viral infection. | Front Cell Infect Microbiol | 2022 | 36405960 | PubTator, text mining | PubMed |
| Bortezomib induces cellular senescence in A549 lung cancer cells by stimulating telomere shortening. | Hum Exp Toxicol | 2022 | 36401358 | PubTator, text mining | PubMed |
| Telomere organization and the interstitial telomeric sites involvement in insects and vertebrates chromosome evolution. | Genet Mol Biol | 2022 | 36394537 | PubTator, text mining | PubMed |
| New Insights into Melanoma Tumor Syndromes. | JID Innov | 2022 | 36387771 | PubTator, text mining | PubMed |
| Lung adenocarcinoma relapse with emerging EGFR mutation following complete response of small cell lung cancer warrants routine re-biopsy: A case report. | Front Oncol | 2022 | 36387208 | PubTator, text mining | PubMed |
| Whole exome sequencing identified a novel POT1 variant as a candidate pathogenic allele underlying a Li-Fraumeni-like family. | Front Oncol | 2022 | 36387164 | PubTator, text mining | PubMed |
| A case report of primary cardiac angiosarcoma with DNMT3A gene mutation. | Front Oncol | 2022 | 36387074 | PubTator, text mining | PubMed |
| Long non-coding RNA PCAT19 safeguards DNA in quiescent endothelial cells by preventing uncontrolled phosphorylation of RPA2. | Cell Rep | 2022 | 36384122 | PubTator, text mining | PubMed |
| Predictors of large cell transformation in patients with Sezary Syndrome-A retrospective analysis. | PLoS One | 2022 | 36383618 | PubTator, text mining | PubMed |
| Particularities of Neurological Manifestations in Adult T-Cell Leukemia/Lymphoma: Need for a Multidisciplinary Approach-A Narrative Review. | Medicina (Kaunas) | 2022 | 36363509 | PubTator, text mining | PubMed |
| Diagnostic and Therapeutic Implications of Long Non-Coding RNAs in Leukemia. | Life (Basel) | 2022 | 36362925 | PubTator, text mining | PubMed |
| POLDIP3: At the Crossroad of RNA and DNA Metabolism. | Genes (Basel) | 2022 | 36360158 | PubTator, text mining | PubMed |
| The Molecular Interplay between Human Oncoviruses and Telomerase in Cancer Development. | Cancers (Basel) | 2022 | 36358677 | PubTator, text mining | PubMed |
| TPP1 promoter mutations cooperate with TERT promoter mutations to lengthen telomeres in melanoma. | Science | 2022 | 36356143 | PubTator, text mining | PubMed |
| Attitudes of Australian dermatologists on the use of genetic testing: A cross-sectional survey with a focus on melanoma. | Front Genet | 2022 | 36353112 | PubTator, text mining | PubMed |
| Circulating tumour DNA biomarkers in savolitinib-treated patients with non-small cell lung cancer harbouring MET exon 14 skipping alterations: a post hoc analysis of a pivotal phase 2 study. | Ther Adv Med Oncol | 2022 | 36339926 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/25913/papers?page=22